news aktuell GmbH

The UAE Country of Honor at Thessaloniki International Fair TIF 86: Minister of Economy Heads UAE’s Delegation to Greece with Extensive Government & Private-Sector Participation

Del
UAE Minister of Economy, H.E. Abdulla Bin Touq Al Marri
UAE Minister of Economy, H.E. Abdulla Bin Touq Al Marri

Abu Dhabi07/09/2022,

- Picture is available at AP Images (http://www.apimages.com) -

The United Arab Emirates (UAE) will participate — with a high-ranking delegation headed by the UAE Minister of Economy, H.E. Abdulla Bin Touq Al Marri — in the Thessaloniki International Fair TIF 86, which will be held in Greece from 10 to 18 September 2022.

The UAE will serve as the Country of Honor at the 86th Thessaloniki International Fair (TIF) in Greece, participating with a prominent delegation that comprises 60 government and private-sector entities.

The delegation will showcase the country’s important economic developments, the latest UAE technology-related products, and the nation’s new economic sectors.

The UAE’s participation in TIF 86 comes in the context of the nation’s pursuit of attracting USD 150 billion in inward foreign investment over the next 9 years to become one of the top 10 global investment destinations — particularly in the New Economy sectors — by 2030.

The UAE’s participation in TIF 86 aims to boost cooperation with the business communities in Greece, the Balkans, and European markets to give momentum to economic development & mutual investments in the UAE and these countries. The UAE’s participation is set to make a lasting impression due to the strength of its delegation

  • The UAE aims to create a successful knowledge-based economy and to create a world-class healthcare system.
  • UAE is investing heavily in creating a world-leading regulatory framework for IT / AI ventures, providing infrastructure to build the best possible tech-investment ecosystem
  • The UAE’s pharmaceutical market presents significant growth opportunities for multinational drug makers.
  • The UAE Government is focused on more than doubling the contribution of industrial manufacturing to the UAE’s GDP to 25 percent.

Long version of this press release can be found at:

https://www.presseportal.de/nr/165110?langid=2

Contact:
Rana Elshorbagy       
rana.elshorbagy@strategic.ae

Bilder

UAE Minister of Economy, H.E. Abdulla Bin Touq Al Marri
UAE Minister of Economy, H.E. Abdulla Bin Touq Al Marri
Last ned bilde

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din epostadresse under for å få de nyeste sakene fra news aktuell GmbH på epost fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

R-Biopharm AG: Flu tests from R-Biopharm also detect new virus variants25.11.2022 11:23:27 CET | Press release

Darmstadt, November 25, 2022: The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany. "Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explains Dr. Andreas Simons, Head of Product Management at R-Biopharm. " Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations." This means laboratories can continue to reliably conf

Grunenthal Group: Janneke van der Kamp joins Grünenthal as new Chief Commercial Officer22.11.2022 11:27:30 CET | Press release

(Aachen, Germany): Grünenthal today announced that Janneke van der Kamp will join Grünenthal as the new Chief Commercial Officer (CCO), effective 1 March 2023. Janneke van der Kamp joins Grünenthal from Novartis, where she most recently served as Head of Pharma Region Europe. The Dutch native brings broad experience in the pharmaceutical industry from several roles including General Manager, Global Neurosciences Franchise Head and Global Head of Product and Portfolio Strategy for the entire Novartis Pharma portfolio. She worked closely with Research & Development and the Licensing & Acquisitions teams to strengthen the company’s pipeline. Janneke van der Kamp has vast expertise in launching and growing key brands across several disease areas. She is a studied chemist and holds an MBA from INSEAD. As CCO of Grünenthal, Janneke van der Kamp will be responsible for the entire Global Commercial Organisation and serve as a member of the Corporate Executive Board. Her focus will be to contin

The high-performance single-seater 777 hypercar is born in Monza22.11.2022 11:05:00 CET | Press release

(Monza, Italy): – The 777 hypercar is a new Italian hypercar born of the excellent partnership with Andrea Levy, Dallara, and Gibson, built from technology used in motorsports and all informations and images are on www.777hypercar.com. 777 hypercar is built by 777 Motors, the car manufacturer based in the Autodromo Nazionale Monza and founded by Andrea Levy, an entrepreneur, car collector, racing driver, and president of MIMO Milano Monza Motorshow. The 777 hypercar project will be presented on November 22, limited to just 7 units, each of which will cost 7 million euros. 777 hypercar is at the top for performance thanks to an FIA-homologated carbon monocoque developed by Dallara, which generate an incredible downforce of 2,100 kg at a speed of 370 km/h, an extremely low weight of 900 kg, and a lateral acceleration from 3.5 to 4 g that keeps the car glued to the asphalt, giving an incredible estimate lap time of just 1 minute and 33 seconds in the Monza Circuit. The engine is a natural

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom